New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs

Researchers have developed a new protease inhibitor effective against mutating strains of the human AIDS virus that are resistant to current drugs, according to a just-released report in the peer-reviewed Journal of the American Chemical Society.

The paper will be published on the web on Feb. 4 and will be in the journal's Feb. 17 print edition. The American Chemical Society is the world's largest scientific society.

Most AIDS drugs disable the human immunodeficiency virus (HIV) by latching onto an enzyme, such as a protease, that the virus needs to multiply. However, HIV quickly mutates and becomes resistant to individual inhibitors within weeks.

The most successful treatment to date tries to overwhelm HIV with two or three of these drugs simultaneously in a so-called "combination therapy," but even this approach eventually loses effectiveness.

Researchers at The Scripps Research Institute in La Jolla, Calif. think they now know how HIV adapts so readily to the current treatments. Over time, HIV proteases apparently change structure so that the inhibitors can no longer bind tightly. "We have studied the mutation pattern of HIV protease from patients who take the existing drugs and found that the enzyme often rejects the drug by reducing the size of the drug binding site," says Scripps chemist Chi-Huey Wong, Ph.D.

The scientists then looked at the corresponding binding site on current HIV protease inhibitors and found that most of them have large chemical structures that interact with the constricted areas in drug-resistant proteases. So they redesigned the drugs, giving them a smaller chemical group at the critical binding site. In laboratory tests, the new class of inhibitors was effective against both HIV protease and its drug-resistant mutants. "More importantly," adds Wong, "no resistant mutants were detected in cell culture after one year the new drug may last longer as the chance for development of drug resistance is lower

Contact: Nancy Blount
American Chemical Society

Page: 1 2

Related medicine news :

1. Protease inhibitor could help prevent alzheimers
2. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
3. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
4. Answers To Access, Adherence And Tolerance Of Protease Inhibitors
5. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors
6. Inhibitors prevent aggresome formation associated with some forms of ALS
7. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw
8. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
9. ACE-Inhibitors Score High In Reducing Heart Attack Deaths
10. Could skin cells become brain cells?
11. Could autoantibodies predict future disease in healthy people?

Post Your Comments:

(Date:8/31/2020)... ... August 31, 2020 , ... ... to dental groups in the United States, today announced the grand opening of ... CA. , Patients will enjoy convenient hours, a comfortable office, and full-service ...
(Date:8/31/2020)... ... ... Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent time in the ... anxiety, immense stress, and right now are needing serious relief from a constant state of ... are experiencing a great degree of emotional discomfort, be it fear or worrying about their ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... experience working, both directly with persons with autism and other developmental disabilities, as ... includes early intervention, parent education, adolescents with autism, school consultation, and staff development. ...
(Date:8/29/2020)... , ... August 29, 2020 , ... When professor and ... with greater ease than most people would. Rather than become melancholic, however, he put ... advice on achieving one’s dreams. Randy Pausch took a negative situation and turned it ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , Hespiro™ is a ... respiratory conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It ... gas and scrubs it free of carbon dioxide in a completely closed “rebreather” ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... ... , ... Cloudticity announced today that Network Products Guide, industry’s ... the 15th Annual 2020 Network PG’s IT World Awards®. , The IT World ... Guide honoring achievements of world’s best in organizational performance, product and service innovations, ...
(Date:8/27/2020)... Texas (PRWEB) , ... August 27, 2020 , ... Austin ... Texas – is pleased to announce Dr. David Szalay, DDS, MD, has joined the ... treat patients in the new Pflugerville office, which is scheduled to open this fall. ...
(Date:8/27/2020)... ... August 27, 2020 , ... The GHT Companies , a leading developer ... Feeding San Diego with a press conference at its manufacturing facility in ... check of $5,000.00+ representing an overall donation result exceeding $30,000 to Feeding San Diego, ...
Breaking Medicine Technology:
Cached News: